SUCRALFATO 1G FCO 40 TAB LGEN COBRE Riesgo de desarrollo de inhibidores

Description

Riesgo de desarrollo de inhibidores contra el factor VIII

SUSTANCIA: CRAVICEM TAB

Trastuzumab 440 mg

PRINCIPIO ACTIVO: ZOLMITRIPTANO

SUCRALFATO 1G FCO 40 TAB LGEN COBRE Riesgo de desarrollo de inhibidoresPrincipio activo: Sucralfato Dosis y va de administracin: La que el mdico seale. COFEPRIS: 393M2008 SSA IV No te automediques. Consulta a tu mdico. Su venta requiere receta mdica.

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products